[CYCC] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
13-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -6.62%
YoY- 8.08%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 150 -
PBT -2,452 -1,510 -2,752 -2,174 -2,090 -2,110 -2,370 2.29%
Tax -286 -290 -449 -273 -307 -268 -352 -12.93%
NP -2,166 -1,220 -2,303 -1,901 -1,783 -1,842 -2,018 4.83%
Tax Rate - - - - - - - -
Total Cost 2,166 1,220 2,303 1,901 1,783 1,842 2,168 -0.06%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -1,345.33 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.56 -1.42 -2.68 -2.21 -2.07 -2.70 -2.96 -67.07%
EPS Diluted -0.56 -1.42 -2.68 -2.21 -2.07 -2.70 -2.96 -67.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.